Assessment of TB patient cost - what about the mitigation strategy?

Chiang, C-Y; Lin, H-H; Fu, H

Chiang, C-Y; Lin, H-H; Fu, H.

Afiliación

Chiang CY; Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, International Union Against Tuberculosis and Lung Disease, Paris, France.
Lin HH; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, Global Health Program, College of Public Health, National Taiwan University, Taipei, Taiwan.
Fu H; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Int J Tuberc Lung Dis ; 26(12): 1101-1103, 2022 Dec 01.

Article en En | MEDLINE | ID: mdl-36447319

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google